CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
OPERATING ACTIVITIES
Net loss	$ (15,383)	$ (15,925)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	4,942	5,240
Equity-based compensation	5,043	7,222
Impairment related and other	215	0
Other loss (income), net	156	(1,537)
Deferred tax asset	(5)	(13)
Contingent consideration	16	172
Changes in operating assets and liabilities - net of acquisitions:
Accounts receivable, net	(8,659)	(662)
Prepaid expenses and other assets	19	(636)
Accounts payable	(2,452)	(551)
Accrued expenses	207	1,063
Accrued compensation and benefits	(5,658)	(2,030)
Deferred revenue	6,191	2,755
Other liabilities	2,204	496
Cash flows used in operating activities	(13,164)	(4,406)
INVESTING ACTIVITIES
Capital expenditures	(995)	(2,340)
Change in restricted cash	(148)	140
Proceeds from other distributions	46	1,415
Ownership acquisition, net of cash acquired	(2,168)	(1,257)
Cash flows used in investing activities	(3,265)	(2,042)
FINANCING ACTIVITIES
Acquisition of noncontrolling interest in subsidiary equity	(5,515)	(3,952)
Borrowings of short-term debt and note payable	4,674	820
Repayment of notes payable and capital lease obligations	(145)	(24)
Purchase of treasury stock	(4,048)	(1,704)
Tax withholdings related to equity-based awards	(1,529)	(3,494)
Other financing activities	0	65
Cash flows used in financing activities	(6,563)	(8,289)
Effect of exchange rate on cash flows and cash equivalents	(29)	(117)
Net decrease in cash and cash equivalents	(23,021)	(14,854)
Cash and cash equivalents at beginning of period	76,313	103,134
Cash and cash equivalents at end of period	$ 53,292	$ 88,280